Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-d-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold
Article first published online: 27 SEP 2005
DOI: 10.1111/j.1399-3011.2005.00291.x
Additional Information
How to Cite
Ballet, S., Frycia, A., Piron, J., Chung, N., Schiller, P., Kosson, P., Lipkowski, A. and Tourwé, D. (2005), Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-d-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold. The Journal of Peptide Research, 66: 222–230. doi: 10.1111/j.1399-3011.2005.00291.x
Publication History
- Issue published online: 5 DEC 2008
- Article first published online: 27 SEP 2005
- Dates: Received 23 March 2005 Accepted 10 July 2005
- Abstract
- Article
- References
- Cited By
Keywords:
- 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold;
- conformational restriction;
- dermorphin analogues
Abstract: The synthesis of conformationally restricted dipeptidic moieties 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba)-Gly ([(4S)-amino-3-oxo-1,2,4,5-tetrahydro-1H-2-benzazepin-2-yl]-acetic acid) and 8-hydroxy-4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Hba)-d-Ala ([(4S)-amino-8-hydroxy-3-oxo-1,2,4,5-tetrahydro-benzo[c]azepin-2-yl]-propionic acid) was based on a synthetic strategy that uses an oxazolidinone as an N-acyliminium precursor. Introducing these Aba scaffolds into the N-terminal tetrapeptide of dermorphin (H-Tyr-d-Ala-Phe-Gly-Tyr-Pro-Ser-NH2)-induced remarkable shifts in affinity and selectivity towards the opioid μ- and δ-receptors. This paper provides the synthesis and biological in vitro and in vivo evaluation of constricted analogues of the N-terminal tetrapeptide H-Tyr-d-Ala-Phe-Gly-NH2, which is the minimal subunit of dermorphin needed for dermorphin-like opiate activity.

1747-0285/asset/olbannercenter.gif?v=1&s=9c82acf9622680240805c0226e5f5891925376a7)
